TABLE 4.

Odds ratio for left ventricular hypertrophy by ankle brachial index in stratification analysis

		1.04≤ABI≤1.11		1.12≤ABI≤1.20		1.21≤ABI < 1.40
	0.9 < ABI≤1.03	Crude OR (95% CI); P‐value	Adjusted OR (95% CI); P‐value	Crude OR (95% CI); P‐value	Adjusted OR (95% CI); P‐value	Crude OR (95% CI); P‐value	Adjusted OR (95% CI); P‐value
Sex
Male	Reference	1.11 (0.79–1.56); 0.558	1.07 (0.73–1.57); 0.726	1.33 (0.96–1.85); 0.085	1.59 (1.10–2.29); 0.013	1.56 (1.14–2.13); 0.006	2.09 (1.47–2.98); <0.001
Female	Reference	1.02 (0.82–1.26); 0.861	1.10 (0.87–1.39); 0.410	1.49 (1.20–1.86); <0.001	1.60 (1.26–2.03); <0.001	1.44 (1.15–1.80); 0.001	1.67 (1.30–2.14); <0.001
Years
≤60	Reference	1.06 (0.84–1.33); 0.649	1.14 (0.89–1.47); 0.303	1.52 (1.21–1.90); <0.001	1.74 (1.36–2.24); <0.001	1.57 (1.25–1.97); <0.001	2.17 (1.69–2.81); <0.001
>60	Reference	1.03 (0.76–1.39); 0.847	1.03 (0.74–1.42); 0.878	1.23 (0.92–1.66); 0.167	1.32 (0.96–1.83); 0.092	1.19 (0.88–1.60); 0.254	1.31 (0.94–1.83); 0.107
History of CAD
No	Reference	1.07 (0.88–1.30); 0.509	1.13 (0.92–1.39); 0.254	1.41 (1.22–1.78); <0.001	1.70 (1.38–2.09); <0.001	1.54 (1.27–1.86); <0.001	2.03 (1.64–2.51); <0.001
Yes	Reference	0.92 (0.52–1.63); 0.770	1.01 (0.53–1.90); 0.983	1.08 (0.60–1.94); 0.800	1.14 (0.59–2.21); 0.697	0.73 (0.41–1.30); 0.290	0.79 (0.41–1.54); 0.487
History of DM
No	Reference	1.05 (0.87–1.27); 0.626	1.11 (0.91–1.36); 0.311	1.42 (1.18–1.71); <0.001	1.67 (1.36–2.04); <0.001	1.38 (1.15–1.66); 0.001	1.80 (1.46–2.22); <0.001
Yes	Reference	0.95 (0.48–1.90); 0.893	0.88 (0.40–1.92); 0.739	1.23 (0.63–2.42); 0.546	1.07 (0.49–2.33); 0.874	1.85 (0.97–3.54); 0.062	1.87 (0.87–4.02); 0.109

Adjusted: age, sex, body mass index, height, weight, systolic blood pressure, diastolic blood pressure, serum glucose, triglyceride, cholesterol, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, blood urea nitrogen, the history of stroke, coronary artery disease, and diabetes mellitus.

Abbreviations: 95% CI, 95% confidence interval; OR, odds ratio.